Login

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma 00:00:00

Share On Facebook Share On Twitter

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Telekom Malaysia Berhad received a Special Mention at the 2021 Building Trust Awards for their efforts in fostering internal trust through a robust corporate governance framework.
00:10:00
Johan Hårdén, CEO at Allgon is interviewed about the start of 2020 and what lies ahead | Ola Samelius, EXECUTIVE PRESIDENT, Allgon AB (publ) ALLG B:STO
00:10:00
Dr. Doug Gurr: Bridging Worlds for a Sustainable Future | Doug Gurr - Museum Director of Natural History Museum Consulting
00:10:00
Interview with Ernesto Balarezo, CEO of Sierra Metals: Strategic Initiatives, Turnaround Success, and Future Prospects
00:10:00
A2A's Alumni to Alumni highlights inspiration, insights, and innovation, featuring an NTN24 interview with Pedro David Espinoza, CEO of SmileyGo.
00:10:00
Polymetals Resources Eyes Strong Cash Flow with Endeavor Mine Restart | David Sproule, Chairman , Polymetals Resources Ltd.
00:10:00
Tilaknagar Industries' Financial Turnaround: Chairman Amit Dhanuka on Overcoming Stress and Achieving Profitability|Amit Dahanukar,Chairman and Managing Director,Tilaknagar Industries Ltd.
00:10:00
A mission-driven investment firm seeking to create outstanding|Pete Oberle,Managing Partner,Trailhead Capital
00:00:00
Michael Knaap Chief Executive Officer and Managing Director, Monash IVF Group Ltd
00:10:00
Gérard Perrier Industrie operates within the fertilizer production facilities of Azomures S.A., focusing on industrial engineering solutions.
00:10:00
The Power of Being a Generalist: Insights from David Epstein | Podcast Episode on In Good Company by Norges Bank Investment Management
00:10:00
Invest in only a few new companies each year, allowing them to concentrate their time|Joo Hock Chua,Managing Partner,Vertex Ventures

© 2017 - Neuhu+